Management of Madhumeha with Vallipanchmool Churna – A Case Study.

Diabetes Mellitus is a major health problem in the whole world. In spite of tremendous advancements of the modern system of medicine as OAD (oral anti-diabetic drug) and insulin therapy, to date, an ideal drug that can control hyperglycemia is still a distant dream. It has been a challenge for Ayurveda to search for additional effective solutions resulting in the better management of the disease. There is a need for effective, safe and potent medicine which can control hyperglycemia related to type II diabetes and has no side effects. In this case study, we used Ayurvedic medicine ‘Vallipanchmoolchurna’ mentioned in Sushruta Samhita in a single case study which was done on the use of Vallipanchmool churna on type II Diabetes Mellitus. A significant reduction was seen in blood sugar level fasting and post-meal.

Download Full-text

Management of Prameha with Mustadi Kwatha - A Case Study

Journal of Ayurveda and Integrated Medical Sciences (JAIMS) ◽

10.21760/jaims.v3i4.13316 ◽

2018 ◽

Vol 3 (4) ◽

Author(s):

Dr. Akshay H. Malshikare ◽

Dr. Sharada Chikurte

Keyword(s):

Type Ii Diabetes ◽

Single Case ◽

Type Ii Diabetes Mellitus ◽

Ayurvedic Medicine ◽

Type Ii ◽

Single Case Study ◽

Major Health Problem ◽

Major Health ◽

Uncontrolled Diabetes

Diabetes is a major health problem in whole world. In spite of many drugs available, uncontrolled diabetes remains a challenge. Moreover, some anti-diabetic drugs are on the verge of withdrawal due to its adverse effects. So, there is an acute need for a new effective and safe drug. So in this case study we used Ayurvedic medicine ‘Mustadi Kwatha’ mentioned in Bhaishajya Ratnawali in Prameha Chikitsa. A single case study was done on use of Mustadi Kwatha on Type II Diabetes Mellitus. Significant reduction was seen in blood sugar level fasting and post-prandial.

Download Full-text

SARS-CoV-2 and The Case for Empirical Treatment (Preprint)

10.2196/preprints.22442 ◽

2020 ◽

Author(s):

Richard P Bartlett ◽

Alexandria Watkins

Keyword(s):

Diabetes Mellitus ◽

Type Ii Diabetes ◽

The United States ◽

Type Ii Diabetes Mellitus ◽

Outpatient Setting ◽

Empirical Treatment ◽

Residual Effects ◽

Type Ii ◽

West Texas

UNSTRUCTURED Background: This is an outpatient case study that examines two patients in the United States with unique cases that involve oncology, hypertension, Type II Diabetes Mellitus, and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), also known as COVID-19. This case study involves two patients in the outpatient setting - treated via telemedicine, with laboratory-confirmed SARS-CoV-2 infection in the West Texas region between March 29th, 2020, and May 14th, 2020. Case Report: The first patient is a 63-year-old female, non-smoker, who is diagnosed with Waldenstrom’s Macroglobulinemia (2012) and Primary Cutaneous Marginal Zone Lymphoma (2020) and the second patient is a 38-year-old male, non-smoker, who has the following comorbidities: Type II Diabetes Mellitus (DM), hypertension, and gout. Both patients were empirically started on budesonide 0.5mg nebulizer twice daily, clarithromycin (Biaxin) 500mg tab twice daily for ten days, Zinc 50mg tab twice daily, and aspirin 81mg tab daily. Both patients have fully recovered with no residual effects. Conclusion: The goal is to call attention to the success of proactive, early empirical treatment, combining a classic corticosteroid (budesonide) administered via a nebulizer and an oral macrolide antibiotic known as clarithromycin (Biaxin).

Download Full-text

Importance of Geospatial Heterogeneity in Chronic Disease Burden for Policy Planning in an Urban Setting Using a Case Study of Singapore

International Journal of Environmental Research and Public Health ◽

10.3390/ijerph18094406 ◽

2021 ◽

Vol 18 (9) ◽

pp. 4406

Author(s):

Ken Wei Tan ◽

Joel R. Koo ◽

Jue Tao Lim ◽

Alex R. Cook ◽

Borame L. Dickens

Keyword(s):

Diabetes Mellitus ◽

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Chronic Disease ◽

Type Ii Diabetes ◽

Census Data ◽

Type Ii Diabetes Mellitus ◽

Urban Setting ◽

Type Ii

Chronic disease burdens continue to rise in highly dense urban environments where clustering of type II diabetes mellitus, acute myocardial infarction, stroke, or any combination of these three conditions is occurring. Many individuals suffering from these conditions will require longer-term care and access to clinics which specialize in managing their illness. With Singapore as a case study, we utilized census data in an agent-modeling approach at an individual level to estimate prevalence in 2020 and found high-risk clusters with >14,000 type II diabetes mellitus cases and 2000–2500 estimated stroke cases. For comorbidities, 10% of those with type II diabetes mellitus had a past acute myocardial infarction episode, while 6% had a past stroke. The western region of Singapore had the highest number of high-risk individuals at 173,000 with at least one chronic condition, followed by the east at 169,000 and the north with the least at 137,000. Such estimates can assist in healthcare resource planning, which requires these spatial distributions for evidence-based policymaking and to investigate why such heterogeneities exist. The methodologies presented can be utilized within any urban setting where census data exists.

Download Full-text

Study of Prevalence of Hypomagnesemia in Patients with Type II Diabetes Mellitus

The Journal of Medical Sciences ◽

10.5005/jp-journals-10045-0057 ◽

2017 ◽

Vol 3 (2) ◽

pp. 55-58 ◽

Cited By ~ 1

Author(s):

NH Rekha ◽

MS Bharath ◽

SP Channakeshava

Keyword(s):

Diabetes Mellitus ◽

Type Ii Diabetes ◽

Negative Impact ◽

Serum Magnesium ◽

Fasting Blood Glucose ◽

Type Ii Diabetes Mellitus ◽

Diabetic Patients ◽

Type Ii ◽

Major Health ◽

Medical College

ABSTRACT Introduction Diabetes mellitus is a common metabolic disorder. Prevalence of diabetes is increasing globally and it is one of the major health problems of the 21st century. The disturbance in serum magnesium (SMg) has been reported among patients with type II diabetes mellitus. Hypomagnesemia has negative impact on glucose homeostasis and insulin sensitivity in patients with type II diabetes mellitus. Aim This study was undertaken to know the prevalence of hypomagnesemia in patients with type II diabetes mellitus and its relation with glycated hemoglobin (HbA1c). The study was conducted on 200 patients with type II diabetes and 100 healthy controls at RajaRajeswari Medical College & Hospital, Bengaluru. Results Out of 200 diabetic patients, 115 (57%) had hypomagnesemia. We observed mean SMg (1.7 mg) significantly low in diabetic patients compared with controls (2.1 mg). We also found HbA1c was high (9%) in hypomagnesemia patients. We found that diabetic hypomagnesemic patients had high mean fasting blood glucose (242.6 mg%) and postprandial blood sugar (313 mg%) than controls. How to cite this article Rekha NH, Bharath MS, Channakeshava SP. Study of Prevalence of Hypomagnesemia in Patients with Type II Diabetes Mellitus. J Med Sci 2017;3(2):55-58.

Download Full-text